Author:
Popova E. V., ,Brylev L. V.,Davydovskaya M. V.
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Biogen Idec, Natalizumab Safety Review [Russian translation] (2012).
2. C. Bozic, L. M. Cristiano, A. Natarajan, et al., “Utilisation and safety of natalizumab in patients with relapsing multiple sclerosis,” Multiple Sclerosis, 16, 494 (2010).
3. P. K. Coyle, J. F. Foley, E. J. Fox, et al., “Best practice recommendations for the selection and management of patients with MS receiving natalizumab therapy,” Multiple Sclerosis, 15, 26–36 (2009).
4. A. Egli, L. Infanti, A. Dumoulin, et al., “Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors,” J. Infect. Dis., 199, 837–846 (2009).
5. E. Havrdova, S. Galetta, M. Hutchinson, et al., “Effects of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the natalizumab safety and efficacy in relapsing-remitting multiple sclerosis “AFFIRM” study,” Lancet Neurol., 8, No. 3, 254–260 (2009).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献